Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.44K Sell
104
-339
-77% -$30.9K ﹤0.01% 330
2026
Q1
$45.5K Buy
443
+4
+0.9% +$452 0.02% 183
2025
Q4
$55K Sell
439
-8
-2% -$1.02K 0.03% 166
2025
Q3
$59.9K Buy
447
+11
+3% +$1.44K 0.03% 179
2025
Q2
$59.3K Buy
436
+2
+0.5% +$264 0.04% 144
2025
Q1
$57.6K Sell
434
-104
-19% -$13.2K 0.04% 158
2024
Q4
$62.4K Buy
+538
New +$62.2K 0.05% 129

Other funds holding ABT

Hurley Capital's ABT Position: Q2 2026 in Review

Hurley Capital reduced its Abbott (ABT) stake by 77% in Q2 2026, selling an estimated $30.9K and leaving 104 shares worth $9.44K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

Hurley Capital first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $62.4K in Q4 2024. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Hurley Capital held 104 shares of Abbott worth $9.44K as of Q2 2026.
  • Hurley Capital sold 339 Abbott shares in Q2 2026, an estimated $30.9K.
  • Abbott made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #330 holding.
  • Hurley Capital first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Hurley Capital's Abbott position peaked at $62.4K in Q4 2024.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.